Sanai Health Industry Group Company (HKG:1889) has filed a second appeal seeking to overturn a civil judgment requiring it to honor payments under a finance lease and related guarantees, according to a Friday filing with the Hong Kong Stock Exchange.
In April, the No. 4 Intermediate People's Court of Beijing upheld Sanai Health's obligation to pay 67.4 million yuan in principal, 57.6 million yuan in default interest, 2.9 million yuan in penalties, and legal and insurance fees owed by its former subsidiary, Fujian Sanai Pharmaceutical.
In its latest appeal, Sanai Health asked the High People's Court of Beijing to declare the finance lease and guarantee agreements invalid and to dismiss all claims.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。